cancers杂志投稿

（部份，英文）：1. Long, M.J., et al., A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?Breast Cancer Research and Treatment, 2011. 127(3): p. 705-712.2. Gong, C., et al., Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer.Journal of Biological Chemistry, 2011. 286(21): p. 19127-19137.3. Chen, J.Q., et al., CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3.Cancer Cell, 2011. 19(4): p. 541-555.4. Wang, Y.H., et al., GeneSearch Breast Lymph Node Assay for the diagnosis of sentinel lymph nodes of breast cancer - CBCSG-001a: China validation study.Ejc Supplements, 2010. 8(3): p. 154-154.5. Gong, C., et al., Markers of Tumor-Initiating Cells Predict Chemoresistance in Breast Cancer.Plos One, 2010. 5(12).6. Wang, Y.S., et al., China Validation Study of GeneSearch (TM) Breast Lymph Node Assay for the Diagnosis of Sentinel Lymph Nodes of Breast Cancer - CBCSG-001a Interim Results.Cancer Research, 2009. 69(24): p. 544S-545S.7. Rao, N.Y., et al., Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients.Breast Cancer Research and Treatment, 2009. 116(3): p. 563-570.8. Rao, N.Y., et al., Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients.Breast Cancer Research and Treatment, 2009. 113(3): p. 467-477.9. Cao, A.Y., et al., The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.Breast Cancer Research and Treatment, 2009. 114(3): p. 457-462.10. Cao, A.Y., et al., Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.Breast Cancer Research and Treatment, 2009. 115(1): p. 51-55.11. Wang, Y.S., et al., China multicenter study of sentinel node biopsy substituting axillary node dissection: CBCSG-01 trial.Ejc Supplements, 2008. 6(7): p. 170-171.12. Li, W.F., et al., The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.Breast Cancer Research and Treatment, 2008. 110(1): p. 99-109.13. Yu, F., et al., Iet-7 regulates self renewal and tumorigenicity of breast cancer cells.Cell, 2007. 131(6): p. 1109-1123.14. Hu, X.Q., et al., Stable RNA interference of ErbB-2 gene synergistic with epirubicin suppresses breast cancer growth in vitro and in vivo.Biochemical and Biophysical Research Communications, 2006. 346(3): p. 778-785.15. Gong, C., et al., A double-blind randomized controlled trial of toremifen therapy for mastalgia.Archives of Surgery, 2006. 141(1): p. 43-47.16. Su, F.X., et al., Psychological stress induces chemoresistance in breast cancer by upregulating mdr1.Biochemical and Biophysical Research Communications, 2005. 329(3): p. 888-897.17. Su, F.X., et al., Glutathion S transferase pi indicates chemotherapy resistance in breast cancer.Journal of Surgical Research, 2003. 113(1): p. 102-108.18. Song, E.W., et al., Intrasplenic transplantation of syngenic hepatocytes modified by IFN-gamma gene ameliorates hepatic fibrosis in rats.Transplant International, 2002. 15(9-10): p. 472-478.19. Song, E.W., et al., Blocking CTL-based cytotoxic pathways reduces apoptosis of transplanted hepatocytes.Journal of Surgical Research, 2001. 99(1): p. 61-69.20. Song, E.W., et al., Adenovirus-mediated Bcl-2 gene transfer inhibits apoptosis and promotes survival of allogeneic transplanted hepatocytes.Surgery, 2001. 130(3): p. 502-511.21. Song, E., et al., Rare occurrence of metastatic colorectal cancers in livers with replicative hepatitis B infection.American Journal of Surgery, 2001. 181(6): p. 529-533.(部份，中文)：[1]杨桦,李顺荣,萧俏珍,苏逢锡,. 麦默通系统在乳腺占位性病变中的诊疗作用[J]. 中国全科医学,2009,(21).[2]姚燕丹,黄松音,袁广卿,于风燕,龚畅,贾卫娟,吴畏,宋尔卫,苏逢锡,. Matrigel对不同Her2表达的乳腺癌细胞原位成瘤、增殖、凋亡和转移的影响[J]. 中国病理生理杂志,2009,(12).[3]杨桦,李顺荣,苏逢锡,. 影响保乳手术成功的若干因素分析[J]. 广东医学,2009,(9).[4]李顺荣,苏丹晨,萧俏珍,金亮,吴建南,苏逢锡,. 麦默通旋切系统切除乳腺癌13例[J]. 广东医学,2009,(8).[5]郭巨江,苏逢锡,姚和瑞,陈积圣,. 替代激活的单核细胞促进人乳腺癌细胞SKBR3的生长侵袭[J]. 南方医科大学学报,2007,(4).[6]贾海霞,苏逢锡,郭巨江,宋尔卫,贾卫娟,龚畅,胡孝渠,秦丽,. 乳腺癌新辅助化疗的坐标法定位[J]. 中华普通外科杂志,2006,(3).[7]胡孝渠,宋尔卫,陈积圣,李海刚,于风燕,贾卫娟,龚畅,郭巨江,苏逢锡,. 原位小鼠乳腺癌肝转移模型[J]. 广东医学,2006,(4).[8]胡孝渠,秦利,苏逢锡,姚和瑞,陈积圣,龚畅,郭巨江,于风燕,贾海霞,. 载体介导HER-2RNA干扰治疗乳腺癌研究[J]. 南方医科大学学报,2006,(5).[9]苏逢锡,胡孝渠,. 乳腺癌根治性手术后即刻乳房再造临床应用与评价[J]. 中国实用外科杂志,2006,(4).[10]贾卫娟,苏逢锡,龚畅,胡孝渠,郭巨江,秦丽. 乳腺癌患者非哨兵淋巴结转移预测因素的研究[J]. 中华普通外科杂志,2005,(7).[11]沈镇宙,柳光宇,苏逢锡,何萍青,杨名添,施俊义,盛援,邹强,李亚芬. 多西紫杉醇加表柔比星治疗局部晚期乳腺癌的多中心Ⅱ期临床研究[J]. 中华肿瘤杂志,2005,(2).[12]曾弘,李海刚,曾韵洁,贾渭娟,苏逢锡,. 乳腺叶状囊肉瘤21例临床病理分析[J]. 中山大学学报(医学科学版),2003,(S1).[13]贾卫娟,苏逢锡,陈积圣. 乳腺癌哨兵淋巴结活检126例的临床研究[J]. 中华普通外科杂志,2003,(3).[14]苏逢锡,巴明臣,周晓东,吴仙容,李燕,陈积圣,李君. 活体染料注射法识别乳腺癌患者前哨淋巴结失败及假阴性原因分析[J]. 中华肿瘤杂志,2002,(3).[15]苏逢锡,贾卫娟,何嘉辉,曾韵洁,李海刚,陈积圣. 乳腺癌哨兵淋巴结检出相关临床和组织学因素[J]. 中华外科杂志,2002,(3).[16]巴明臣 ,苏逢锡 ,周晓东 ,吴仙容. 活体染料注射法识别乳腺癌哨兵淋巴结失败及假阴性的原因分析[J]. 新医学,2002,(12).[17]苏逢锡!510120广州,曾韵洁!510120广州,贾渭娟!510120广州,陈积圣!510120广州. 卵巢癌乳腺转移一例病例报告[J]. 中华肿瘤杂志,2001,(2).[18]苏逢锡!510120广州,陈积圣!510120广州,贾卫娟!510120广州硕士研究生,宋尔卫!510120广州博士研究生. BCL-2基因表达与乳腺癌抗凋亡及免疫耐受的关系[J]. 中华普通外科杂志,2001,(9).[19]苏逢锡,贾渭娟,陈积圣,宋尔卫. 乳腺癌细胞可溶性FasL分泌及其对淋巴细胞凋亡的诱导[J]. 肿瘤,2000,(4).[20]苏逢锡!510120广州,贾渭娟!510120广州,李海刚!510120广州,曾韵洁!510120广州,陈积圣!510120广州. 哨兵淋巴结活检对预测乳腺癌腋窝淋巴结转移的价值[J]. 中华外科杂志,2000,(10).

prevent防止,预防treat对待，治疗。根据你问的这些词在语境中应该是治疗的意思special特殊的machines机器electricity电，电力diseases疾病cancer癌症travel旅行themselves他们自己size大小，尺码taste品尝，口味muscles肌肉actually事实上